Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ESPR compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ESPR
Esperion Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ESPR
Esperion Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ESPR, solid
LLY, dashed
ESPR
Esperion Therapeutics, Inc.
Change
3.20
▲
+0.31%
Mkt cap
$818.6M
Revenue
$80M
Q1 FY26
Revenue
$403M
FY25
LLY
ELI Lilly & Co
Change
1,421.25
▲
+0.84%
Regular session
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 4 '26
ESPR
Esperion Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
3.20
▲
+0.31%
Price
1,421.25
▲
+0.84%
$818.6M
Mkt cap
$1.3T
Q1 FY26
$80M
Revenue
$24.4B
Q3 FY26
FY25
$403M
Revenue
$65.2B
FY25
Change
Change
ESPR
3.20
▲
+0.31%
vs
LLY
1,421.25
▲
+0.84%
Regular session
Nov 4 '26